# FDA Inspection 881381 - Sterling Pharma Ringaskiddy Limited - March 28, 2014

Source: https://www.keypedia.com/records/fda_inspections/sterling-pharma-ringaskiddy-limited/90d87d17-a414-4c8c-bc36-158e936ed5dd
Source feed: FDA_Inspections

> FDA Inspection 881381 for Sterling Pharma Ringaskiddy Limited on March 28, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 881381
- Company Name: Sterling Pharma Ringaskiddy Limited
- Inspection Date: 2014-03-28
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1271673 - 2022-04-05](https://www.keypedia.com/records/fda_inspections/sterling-pharma-ringaskiddy-limited/89e1156f-4f0b-4f34-b597-abe2a6cbf7d8)
- [FDA Inspection 1123878 - 2019-09-13](https://www.keypedia.com/records/fda_inspections/sterling-pharma-ringaskiddy-limited/5ee1aa63-81d9-4427-bcd6-c92cc6377382)
- [FDA Inspection 1004237 - 2017-02-03](https://www.keypedia.com/records/fda_inspections/sterling-pharma-ringaskiddy-limited/1b655256-b589-4f87-b328-4646817e53ff)
- [FDA Inspection 694810 - 2010-09-22](https://www.keypedia.com/records/fda_inspections/sterling-pharma-ringaskiddy-limited/ecdfe99c-9450-4ed2-9aae-c9ab320c9108)
- [FDA Inspection 548092 - 2008-10-15](https://www.keypedia.com/records/fda_inspections/sterling-pharma-ringaskiddy-limited/46d70c45-6b39-4f23-8faa-a5f5a523fb9f)

Company: https://www.keypedia.com/companies/sterling-pharma-ringaskiddy-limited/04aaec21-4047-4e85-9bfb-4eb946cad09d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c